Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||||||
---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
Application site irritation | 2.68% - 3.7% | x | ||||||||
Application site dryness | 2.68% - 5.19% | x | ||||||||
Application site pruritus | 2% - 3.7% | x | ||||||||
Cushing's syndrome | x | |||||||||
Folliculitis | x | x | x | x | x | x | x | x | ||
Glycosuria | x | |||||||||
Hyperglycaemia | x | |||||||||
Hypertrichosis | x | x | x | x | x | x | x | |||
Miliaria | x | x | x | x | x | x | x | |||
Pruritus | x | x | x | x | x | x | x | |||
Pyoderma | x | |||||||||
Pigmentation skin | x | |||||||||
Telangiectasia | x | |||||||||
Erythema | x | x | x | x | ||||||
Burning sensation | x | x | x | x | x | |||||
Skin atrophy | x | x | x | x | x | x | x | |||
Skin striae | x | x | x | x | x | x | x | |||
Allergic contact dermatitis | x | x | x | x | x | x | ||||
Leukoderma | x | x | x | x | x | x | ||||
Acneiform eruption | x | x | x | x | x | x | ||||
Comedone | x | |||||||||
Cataract subcapsular | x | |||||||||
Dermatitis perioral | x | x | x | x | x | x | ||||
Secondary adrenocortical insufficiency | x | |||||||||
Plaque psoriasis | x | |||||||||
Secondary infection | x | x | x | x | x | x | x | |||
Stinging | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Skin disorder | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |